Elevated levels of serum prolactin in patients with advanced multiple myeloma

Klára Gadó, Éva Rimanóczi, Ágnes Hasitz, Gábor Gigler, Béla E. Tóth, György M. Nagy, Katalin Pálóczi, Gyula Domján

Research output: Contribution to journalArticle

14 Citations (Scopus)


Background and Objective: The role of prolactin in immunoregulation and normal hemopoiesis is well known. However, prolactin also seems to be involved in the pathomechanism of malignancies and autoimmune diseases. Elevated serum prolactin levels were reported in patients with malignant lymphoma, colon and breast carcinoma, systemic lupus erythematosus and rheumatoid arthritis. Recently we demonstrated prolactin immunostaining in bone marrow cells of patients with multiple myeloma. Design and Methods: Serum prolactin levels of 56 patients with multiple myeloma, as well as serum β2-microglobulin, and interleukin-6 concentrations were determined in this study. Results: Patients with advanced disease showed a significant increase in serum prolactin concentration, while patients with a clinical stage of I and II, and also control patients had normal values. The concentration of serum β2-microglobulin and interleukin-6 changed in parallel with that of serum prolactin in patients with multiple myeloma. Determining serum prolactin levels several times during the disease process in a given patient clearly showed that the prolactin concentration was increasing during the disease progression. Interpretation and Conclusions: Our results indicate a role of prolactin in disease progression in multiple myeloma.

Original languageEnglish
Pages (from-to)231-236
Number of pages6
Issue number4
Publication statusPublished - Dec 1 2001


  • Interleukin-6
  • Multiple myeloma
  • Prolactin
  • β-Microglobulin

ASJC Scopus subject areas

  • Immunology
  • Endocrinology
  • Neurology
  • Endocrine and Autonomic Systems

Fingerprint Dive into the research topics of 'Elevated levels of serum prolactin in patients with advanced multiple myeloma'. Together they form a unique fingerprint.

  • Cite this

    Gadó, K., Rimanóczi, É., Hasitz, Á., Gigler, G., Tóth, B. E., Nagy, G. M., Pálóczi, K., & Domján, G. (2001). Elevated levels of serum prolactin in patients with advanced multiple myeloma. NeuroImmunoModulation, 9(4), 231-236. https://doi.org/10.1159/000049031